These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 17403115)

  • 1. The relationship of heart rate and heart rate variability to non-diabetic fasting glucose levels and the metabolic syndrome: the Cardiovascular Health Study.
    Stein PK; Barzilay JI; Domitrovich PP; Chaves PM; Gottdiener JS; Heckbert SR; Kronmal RA
    Diabet Med; 2007 Aug; 24(8):855-63. PubMed ID: 17403115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of the components of metabolic syndrome on heart rate variability: using the NCEP-ATP III and IDF definitions.
    Min KB; Min JY; Paek D; Cho SI
    Pacing Clin Electrophysiol; 2008 May; 31(5):584-91. PubMed ID: 18439173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns.
    Wang J; Ruotsalainen S; Moilanen L; Lepistö P; Laakso M; Kuusisto J
    Eur Heart J; 2007 Apr; 28(7):857-64. PubMed ID: 17303589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of fasting glucose levels on mortality rate in patients with and without diabetes mellitus and coronary artery disease undergoing percutaneous coronary intervention.
    Muhlestein JB; Anderson JL; Horne BD; Lavasani F; Allen Maycock CA; Bair TL; Pearson RR; Carlquist JF;
    Am Heart J; 2003 Aug; 146(2):351-8. PubMed ID: 12891207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between pulse wave velocity and metabolic syndrome and adiponectin in patients with impaired fasting glucose: cardiovascular risks and adiponectin in IFG.
    Nam JS; Park JS; Cho MH; Jee SH; Lee HS; Ahn CW; Lowe WL; Kim KR
    Diabetes Res Clin Pract; 2009 May; 84(2):145-51. PubMed ID: 19261346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic characteristics and insulin resistance of impaired fasting glucose among the middle-aged and elderly Taiwanese.
    Chen LK; Lin MH; Chen ZJ; Hwang SJ; Tsai ST; Chiou ST
    Diabetes Res Clin Pract; 2006 Feb; 71(2):170-6. PubMed ID: 16026886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of metabolic syndrome, diabetes and prediabetes on cardiovascular events: Tehran lipid and glucose study.
    Hadaegh F; Shafiee G; Ghasemi A; Sarbakhsh P; Azizi F
    Diabetes Res Clin Pract; 2010 Mar; 87(3):342-7. PubMed ID: 20004035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Characteristics of glycemic excursion in different subtypes of impaired glucose intolerance].
    Kang Y; Lu JM; Sun JF; Li CL; Wang XL; Zhang XQ; Lü ZH; Dou JT; Mu YM
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):669-72. PubMed ID: 19595059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ten-year risk of cardiovascular incidence related to diabetes, prediabetes, and the metabolic syndrome.
    Liu J; Grundy SM; Wang W; Smith SC; Vega GL; Wu Z; Zeng Z; Wang W; Zhao D
    Am Heart J; 2007 Apr; 153(4):552-8. PubMed ID: 17383293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risks for type-2 diabetes associated with the metabolic syndrome and the interaction between impaired fasting glucose and other components of metabolic syndrome the study from Jiangsu, China of 5 years follow-up.
    Liu SJ; Guo ZR; Hu XS; Wu M; Chen FM; Kang GD; Zhou H; Guo L
    Diabetes Res Clin Pract; 2008 Jul; 81(1):117-23. PubMed ID: 18485514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classical cardiovascular risk factors according to fasting plasma glucose levels.
    Martinez-Hervas S; Romero P; Hevilla EB; Real JT; Priego A; Martin-Moreno JM; Carmena R; Ascaso JF
    Eur J Intern Med; 2008 May; 19(3):209-13. PubMed ID: 18395166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic syndrome and short-term heart rate variability in young adults. The cardiovascular risk in young Finns study.
    Koskinen T; Kähönen M; Jula A; Mattsson N; Laitinen T; Keltikangas-Järvinen L; Viikari J; Välimäki I; Rönnemaa T; Raitakari OT
    Diabet Med; 2009 Apr; 26(4):354-61. PubMed ID: 19388964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An increase in prevalence of diabetes mellitus in Jordan over 10 years.
    Ajlouni K; Khader YS; Batieha A; Ajlouni H; El-Khateeb M
    J Diabetes Complications; 2008; 22(5):317-24. PubMed ID: 18413210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired fasting glucose is associated with increased arterial stiffness in elderly people without diabetes mellitus: the Rotterdam Study.
    van Popele NM; Elizabeth Hak A; Mattace-Raso FU; Bots ML; van der Kuip DA; Reneman RS; Hoeks AP; Hofman A; Grobbee DE; Witteman JC
    J Am Geriatr Soc; 2006 Mar; 54(3):397-404. PubMed ID: 16551305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of Type 2 diabetes in England and its association with baseline impaired fasting glucose: the Ely study 1990-2000.
    Forouhi NG; Luan J; Hennings S; Wareham NJ
    Diabet Med; 2007 Feb; 24(2):200-7. PubMed ID: 17257284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysglycaemia in non-diabetic hypertensive patients: comparison of the impact of two different classifications of impaired fasting glucose on the cardiovascular risk profile.
    Dell'Omo G; Penno G; Del Prato S; Mariani M; Pedrinelli R
    J Hum Hypertens; 2009 May; 23(5):332-8. PubMed ID: 19078990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum high-molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus.
    Ozeki N; Hara K; Yatsuka C; Nakano T; Matsumoto S; Suetsugu M; Nakamachi T; Takebayashi K; Inukai T; Haruki K; Aso Y
    Metabolism; 2009 Oct; 58(10):1470-6. PubMed ID: 19592051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypomagnesaemia and risk for metabolic glucose disorders: a 10-year follow-up study.
    Guerrero-Romero F; Rascón-Pacheco RA; Rodríguez-Morán M; de la Peña JE; Wacher N
    Eur J Clin Invest; 2008 Jun; 38(6):389-96. PubMed ID: 18489400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence of neuropathy in patients with impaired 60-minute oral glucose tolerance test but normal fasting and 120-minute glucose levels.
    Sahin M; Karatas M; Sahin M; Ertugrul D; Kulaksizoğlu M; Dogruk A; Gokcel A; Tutuncu NB; Guvener ND; Kutlu M
    Minerva Endocrinol; 2008 Dec; 33(4):289-96. PubMed ID: 18923366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are even impaired fasting blood glucose levels preoperatively associated with increased mortality after CABG surgery?
    Anderson RE; Klerdal K; Ivert T; Hammar N; Barr G; Owall A
    Eur Heart J; 2005 Aug; 26(15):1513-8. PubMed ID: 15800018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.